Literature DB >> 31748872

The Liverpool duodenum-and spleen-preserving near-total pancreatectomy can provide long-term pain relief in patients with end-stage chronic pancreatitis.

A R G Sheel1,2, R D Baron1,2, L D Dickerson2, P Ghaneh1,2, F Campbell3, M G T Raraty2, V Yip4, C M Halloran1,2, J P Neoptolemos5.   

Abstract

PURPOSE: Total pancreatectomy may improve symptoms in patients with severe end-stage chronic pancreatitis. This might be achieved whilst preserving both the duodenum- and spleen-(DPSPTP). Mature clinical outcomes of this approach are presented.
METHODS: Single-centre prospective cohort study performed between September 1996 and May 2016. Demographic, clinical details, pain scores and employment status were prospectively recorded during clinic attendance.
RESULTS: Fifty-one patients (33 men, 18 women) with a median (interquartile range) age of 40.8 (35.3-49.4) years, a median weight of 69.8 (61.0-81.5) Kg and a median body mass index of 23.8 (21.5-27.8), underwent intended duodenum-and spleen-preserving near-total pancreatectomy for end-stage chronic pancreatitis. Aetiology was excess alcohol in 25, idiopathic (no mutation) in 15, idiopathic (SPINK-1/CFTR mutations) in two, hereditary (PRSS1 mutation) in seven and one each post-necrotising pancreatitis and obstructive pancreatic duct divisum in 1. The main indication for surgery was severe pain. Findings included parenchymal calcification in 79% and ductal calculi in 24%, a dilated main pancreatic duct in 57% and a dilated main bile duct in 17%, major vascular involvement in 27% and pancreato-peritoneal fistula in 2%. Postoperative complications occurred in 20 patients with two deaths. Median pain scores were 8 (7-8) preoperatively and 3 (0.25-5.75) at 5 years (p = 0.013). Opiate analgesic use was significantly reduced postoperatively (p = 0.048). Following surgery, 22 (63%) of 38 patients of working age re-entered employment compared with 12 (33%) working preoperatively (p = 0.016).
CONCLUSION: Duodenum-and spleen-preserving near-total pancreatectomy provided long-term relief in adult patients with intractable chronic pancreatitis pain, with improved employment prospects.

Entities:  

Keywords:  Chronic pancreatitis; Duodenum-preserving; Hereditary pancreatitis; Spleen-preserving; Surgery; Total pancreatectomy

Mesh:

Year:  2019        PMID: 31748872     DOI: 10.1007/s00423-019-01837-3

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  32 in total

1.  Total pancreatectomy with and without islet cell transplantation for chronic pancreatitis: a series of 85 consecutive patients.

Authors:  Giuseppe Garcea; James Weaver; John Phillips; Cristina A Pollard; Severine C Ilouz; M'balu A Webb; David P Berry; Ashley R Dennison
Journal:  Pancreas       Date:  2009-01       Impact factor: 3.327

2.  Duodenum-preserving pancreatic head resection: 10-year follow-up of a randomized controlled trial comparing the Beger procedure with the Berne modification.

Authors:  Ulla Klaiber; Ingo Alldinger; Pascal Probst; Thomas Bruckner; Pietro Contin; Jörg Köninger; Thilo Hackert; Markus W Büchler; Markus K Diener
Journal:  Surgery       Date:  2016-04-19       Impact factor: 3.982

3.  Age and Disease Duration Impact Outcomes of Total Pancreatectomy and Islet Autotransplant for PRSS1 Hereditary Pancreatitis.

Authors:  Melena D Bellin; Polina Prokhoda; James S Hodges; Sarah J Schwarzenberg; Martin L Freeman; Ty B Dunn; Joshua J Wilhelm; Timothy L Pruett; Varvara A Kirchner; Gregory J Beilman; Srinath Chinnakotla
Journal:  Pancreas       Date:  2018-04       Impact factor: 3.327

4.  Results of partial and total pancreaticoduodenectomy in 117 patients with chronic pancreatitis.

Authors:  F P Gall; E Mühe; C Gebhardt
Journal:  World J Surg       Date:  1981-03       Impact factor: 3.352

5.  The N34S mutation of SPINK1 (PSTI) is associated with a familial pattern of idiopathic chronic pancreatitis but does not cause the disease.

Authors:  J Threadgold; W Greenhalf; I Ellis; N Howes; M M Lerch; P Simon; J Jansen; R Charnley; R Laugier; L Frulloni; A Oláh; M Delhaye; I Ihse; O B Schaffalitzky de Muckadell; A Andrén-Sandberg; C W Imrie; J Martinek; T M Gress; R Mountford; D Whitcomb; J P Neoptolemos
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

6.  The variable phenotype of the p.A16V mutation of cationic trypsinogen (PRSS1) in pancreatitis families.

Authors:  Christopher J Grocock; Vinciane Rebours; Myriam N Delhaye; Ake Andrén-Sandberg; Frank Ulrich Weiss; Roger Mountford; Matthew J Harcus; Edyta Niemczyck; Louis J Vitone; Susanna Dodd; Maiken Thyregod Jørgensen; Rudolf W Ammann; Ove Schaffalitzky de Muckadell; Jane V Butler; Phillip Burgess; Bronwyn Kerr; Richard Charnley; Robert Sutton; Michael G Raraty; Jacques Devière; David C Whitcomb; John P Neoptolemos; Philippe Lévy; Markus M Lerch; William Greenhalf
Journal:  Gut       Date:  2009-12-01       Impact factor: 23.059

7.  [Experiences with duodenum-sparing pancreas head resection in chronic pancreatitis].

Authors:  H G Beger; C Witte; W Krautzberger; R Bittner
Journal:  Chirurg       Date:  1980-05       Impact factor: 0.955

8.  Total pancreatectomy for chronic pancreatitis.

Authors:  M J Cooper; R C Williamson; I S Benjamin; D C Carter; A Cuschieri; I P Linehan; R C Russell; H B Torrance
Journal:  Br J Surg       Date:  1987-10       Impact factor: 6.939

9.  Description and rationale of a new operation for chronic pancreatitis.

Authors:  C F Frey; G J Smith
Journal:  Pancreas       Date:  1987       Impact factor: 3.327

Review 10.  Surgical and endoscopic treatment of pain in chronic pancreatitis: a multidisciplinary update.

Authors:  Y Issa; H C van Santvoort; H van Goor; D L Cahen; M J Bruno; M A Boermeester
Journal:  Dig Surg       Date:  2013-04-26       Impact factor: 2.588

View more
  1 in total

1.  The in situ near-total pancreatectomy (LIVOCADO procedure) for end-staged chronic pancreatitis.

Authors:  Ryan D Baron; Andrea R G Sheel; Ammad Farooq; Jörg Kleeff; Pietro Contin; Christopher M Halloran; John P Neoptolemos
Journal:  Langenbecks Arch Surg       Date:  2021-06-25       Impact factor: 3.445

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.